MeSH tree: C12.050.351.500.852.762
Immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab improved progression-free survival (PFS) in patients with newly diagnosed advanced or recurrent endometrial cancer compared with chemotherapy alone, with further ...
Oct 23, 2023
0
42
The U.S. Food and Drug Administration is considering a ban on certain hair-straightening chemicals that have been used by Black women for years and that research shows may increase the risk of uterine cancer.
Oct 19, 2023
0
42
The U.S. Food and Drug Administration has proposed a ban on the use of formaldehyde in hair relaxers over concerns about its link to respiratory problems and certain cancers.
Oct 18, 2023
0
46
Results from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress ...
Oct 18, 2023
0
51
Endometrial carcinoma, a cancer of the lining of the uterus, is the most common gynecologic malignancy in developed nations. Over the past decade, its incidence has steadily increased (approximately 1% annually) and mortality ...
Oct 12, 2023
0
65
Chemical hair relaxers are heavily marketed to, and commonly used by, Black women to straighten curly or tightly coiled hair. These products are only loosely regulated and are known to contain potentially harmful ingredients, ...
Oct 11, 2023
0
51
TikTok and other short-form video platforms are booming in popularity—for entertainment and for sharing information, including health information.
Oct 5, 2023
0
31
Residing in a more walkable neighborhood protects against the risk of overall obesity-related cancers in women, specifically postmenopausal breast cancer, but also ovarian cancer, endometrial cancer, and multiple myeloma, ...
Oct 4, 2023
0
94
Imagine a device smaller than a toddler's shoebox that can simulate any human disease in multiple organs or test new drugs without ever entering—or harming—the body.
Oct 3, 2023
0
64
Results from the largest ever review of clinical trials in cancer screening, prevention, and early detection (SPED) have been published.
Sep 28, 2023
0
37
